Cargando…

The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion

BACKGROUND: Systemic and local immune suppression plays a significant role in glioma progression. Glioma microenvironment contains both brain-resident microglial cells (MG) and bone marrow-derived macrophages (BMDM), but the study of their functional and immune regulatory activity has been hampered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinton, Laura, Masetto, Elena, Vettore, Marina, Solito, Samantha, Magri, Sara, D’Andolfi, Marta, Del Bianco, Paola, Lollo, Giovanna, Benoit, Jean-Pierre, Okada, Hideho, Diaz, Aaron, Della Puppa, Alessandro, Mandruzzato, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391795/ https://www.ncbi.nlm.nih.gov/pubmed/30813960 http://dx.doi.org/10.1186/s40425-019-0536-x

Ejemplares similares

Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment
por: Mandruzzato, Susanna, et al.
Publicado: (2020)

Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules
por: Pinton, Laura, et al.
Publicado: (2020)

Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy
por: Magri, Sara, et al.
Publicado: (2021)

Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
por: Del Bianco, Paola, et al.
Publicado: (2022)

The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors
por: Musca, Beatrice, et al.
Publicado: (2023)

Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors
por: Magri, Sara, et al.
Publicado: (2020)

Correction to: Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors
por: Magri, Sara, et al.
Publicado: (2020)

Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma
por: Salvalaggio, Alessandro, et al.
Publicado: (2022)

In Brief: Myeloid‐derived suppressor cells in cancer
por: Solito, S, et al.
Publicado: (2017)

Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
por: Damuzzo, Vera, et al.
Publicado: (2015)

The immunosuppression pathway of tumor‐associated macrophages is controlled by heme oxygenase‐1 in glioblastoma patients
por: Magri, Sara, et al.
Publicado: (2022)

Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
por: Pinton, Laura, et al.
Publicado: (2015)

Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
por: Chuntova, Pavlina, et al.
Publicado: (2019)

In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging
por: Zhong, Jia, et al.
Publicado: (2013)

IDH mutation-induced suppression of type-1 anti-glioma immune response
por: Kohanbash, Gary, et al.
Publicado: (2015)

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma
por: Ueda, Ryo, et al.
Publicado: (2007)

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
por: Müller, Sören, et al.
Publicado: (2017)

Editorial: Novel roles for tumor-associated neutrophils
por: Mandruzzato, Susanna, et al.
Publicado: (2022)

IMMU-14. SynNotch chimeric antigen receptor (CAR) T-cells as a potential treatment for diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG)
por: Ferrerosa, Lauren, et al.
Publicado: (2022)

An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art
por: Bergo, E., et al.
Publicado: (2016)

5-Aminolevulinic Acid Fluorescence in High Grade Glioma Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns
por: Puppa, Alessandro Della, et al.
Publicado: (2014)

Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas
por: Okada, Hideho, et al.
Publicado: (2013)

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines
por: Panigrahy, Ashok, et al.
Publicado: (2022)

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

The Microenvironment in Gliomas: Phenotypic Expressions
por: Schiffer, Davide, et al.
Publicado: (2015)

Tumor Microenvironment in Treatment of Glioma
por: Li, Guijie, et al.
Publicado: (2017)

Immune response in glioma’s microenvironment
por: Chen, Houminji, et al.
Publicado: (2021)

Tumor Microenvironment in Glioma Invasion
por: Tamai, Sho, et al.
Publicado: (2022)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020)

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al
por: Chheda, Zinal S, et al.
Publicado: (2023)

Bone Marrow Microenvironment and Tumor Progression
por: Chantrain, Christophe F., et al.
Publicado: (2008)

Targeting the leukemic bone marrow microenvironment
por: von der Heide, Eva Kristin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pcodj4hhdvsfqqh21hv2uj2k1k